HCPCS Level II code L8685 designates an implantable, single-array, rechargeable neurostimulator pulse generator supplied with an extension. These devices are central to neuromodulation therapies for refractory chronic pain and certain neurologic disorders, representing a significant category of durable medical equipment and implantable technology used across the country. The code matters nationally because it standardizes billing for a high-cost, implantable device with implications for coverage policy and device selection.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, coverage and billing considerations commonly encountered with implantable neurostimulators, and national benchmarking topics relevant to device utilization and reimbursement pathways. The publication also highlights common modifiers and administrative elements used with this HCPCS Level II code where applicable.

This summary equips clinicians, billing professionals, and policy analysts with the essential facts about coding and service context for L8685, and points to areas where payor-specific coverage rules and reimbursement practices are commonly reviewed.